Lyssavirus glycoproteins expressing immunologically potent foreign B cell and cytotoxic T lymphocyte epitopes as prototypes for multivalent vaccines

Journal of General Virology

Volumn 80, Issue 9, 1999, Pages 2343-2351

  Desmézières, Emmanuel ^a   Jacob, Yves ^a   Saron, Marie Françoise ^a   Delpeyroux, Francis ^a   Tordo, Noël ^a   Perrin, Pierre ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN; RABIES VACCINE; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; GENOTYPE; HUMORAL IMMUNITY; IMMUNIZATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RABIES VIRUS; T LYMPHOCYTE;

ANIMALIA; CHORIOMENINGITIS VIRUS; EUROPEAN BAT LYSSAVIRUS 1; HUMAN POLIOVIRUS 1; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYSSAVIRUS; MIRIDAE; POLIO VIRUS; POLIOVIRUS; RABIES VIRUS; RNA VIRUSES;

EID: 0344980109     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-9-2343     Document Type: Article

References (36)

1. Aichele, P., Hengartner, H., Zinkernagel, R. M. & Schulz, M. (1990). Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. Journal of Experimental Medicine 171, 1815-1820.
2. Amengual, B., Whitby, J. E., Cobo, J. S. & Bourhy, H. (1997). Evolution of European bat lyssaviruses. Journal of General Virology 78, 2319-2328.
3. An, L.-L. & Whitton, J. L. (1997). A multivalent minigere vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen. Journal of Virology 71, 2292-2302.
4. Bahloul, C., Jacob, Y., Tordo, N. & Perrin, P. (1998). DMA-based immunization for exploring the enlargement of immunological cross-reactivity against the lyssaviruses. Vaccine 16, 417-425.
5. Battegay, M., Oehen, S., Schulz, M., Hengartner, H. & Zinkernagel, R. M. (1992). Vaccination with a synthetic peptide modulates lymphocytic choriomeningitis virus-mediated immunopathology. Journal of Virology 66, 1199-1201.
6. Benmansour, A., Leblois, H., Coulon, P., Tuffereau, C., Gaudin, Y., Flamand, A. & Lafay, F. (1991). Antigenicity of rabies virus glycoprotein. Journal of Virology 65, 4198-4203.
7. Bergmann, C. C., Yao, Q., Ho, C.-K. & Buckwold, S. L. (1996). Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. Journal of Immunology 157, 3242-3249.
8. Bourhy, H., Kissi, B. & Tordo, N. (1993). Molecular diversity of the Lyssavirus genus. Virology 194, 70-81.
9. Delpeyroux, F., Van Wezel, E., Blondel, B. & Crainic, R. (1990). Structural factors modulate the activity of antigenic poliovirus sequences expressed on hybrid hepatitis B surface antigen particles. Journal of Virology 64, 6090-6100.
10. Dietzschold, B., Gore, M., Marchadier, D., Niu, H.-S., Bunschoten, H. M., Otvos, L., Jr, Wunner, W. H., Ertl, H. C., Osterhaus, A. D. & Koprowski, H. (1990). Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. Journal of Virology 64, 3804-3809.
11. Donnelly, J. J., Ulmer, J. B., Shiver, J. W. & Liu, M. A. (1997). DNA vaccines. Annual Review of Immunology 15, 617-648.
12. Doolan, D. L., Hoffman, S. L., Southwood, S., Wentworth, P. A., Sidney, J., Chesnut, R. W., Keogh, E., Appella, E., Nutman, T. B., Lal, A. A., Gordon, D. M., Oloo, A. & Sette, A. (1997). Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles, Immunity 7, 97-112.
13. European Commission (1996). COST/STD-3. Advantages of combined vaccines. Vaccine 14, 693-700.
14. Fekadu, M., Shaddock, J. H., Sanderlin, D. W. & Smith, J. S. (1988). Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses. Vaccine 6, 533-539.
15. + T cells in vivo: a study with the nucleoprotein of the lymphocytic choriomeningitis virus. International Immunology 7, 797-805.
16. Gould, A. R., Hyatt, A. D., Lunt, R., Kattenbelt, J. A., Hengstberger, S. & Blacksell, S. D. (1998). Characterisation of a novel lyssavirus isolated from Pteropid bats in Australia. Virus Research 54, 165-187.
17. Hanke, T., Blanchard, T. J., Schneider, J., Ogg, G. S., Tan, R., Becker, M., Gilbert, S. C., Hill, A. V. S., Smith, G. L. & McMichael, A. (1998). Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. Journal of General Virology 79, 83-90.
18. Jallet, C., Jacob, Y., Bahloul, C., Drings, A., Desmézières, E., Tordo, N. & Perrin, P. (1999). Chimeric lyssavirus glycoproteins with increased immunological potential. Journal of Virology 73, 225-233.
19. Joffret, M.-L., Zanetti, C., Morgeaux, S., Leclerc, C., Sureau, P. & Perrin, P. (1991). Appraisal of rabies vaccine potency by determination of in vitro, specific interleukin-2 production. Biologicals 19, 113-123.
20. Lang, J., Duong, G. H., Nguyen, V. G., Le, T. T., Nguyen, C. V., Kesmedjian, V. & Plotkin, S. A. (1997). Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants. Lancet 349, 1663-1665.
21. Lodmell, D. L., Ray, N. B., Parnell, M. J., Ewalt, L. C., Hanlon, C. A., Shaddock, J. H., Sanderlin, D. S. & Rupprecht, C. E. (1998). DNA immunization protects non-human primates against rabies virus. Nature Medicine 4, 949-952.
22. Maniatis, T., Fritsch, E. F. & Sambrook, J. (1982). Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
23. Martins, L. P., Lau, L. L., Asano, M. S. & Ahmed, R. (1995). DNA vaccination against persistent viral infection. Journal of Virology 69, 2574-2582.
24. Park, J. Y., Peters, C. J., Rollin, P. E., Ksiazek, T. G., Gray, B., Waites, K. B. & Stephensen, C. B. (1997). Development of a reverse transcription-polymerase chain reaction assay for diagnosis of lymphocytic choriomeningitis virus infection and its use in a prospective surveillance study. Journal of Medical Virology 51, 107-114.
25. Pastoret, P.-P., Brochier, B., Aguilar-Setién, A. & Blancou, J. (1997). Vaccination against rabies. In Veterinary Vaccinology, pp. 616-628. Edited by P.-P. Pastoret, J. Blancou, P. Vannier & C. Verschuren. Amsterdam: Elsevier.
26. Perrin, P. (1996). Techniques for the preparation of rabies conjugates. In Laboratory Techniques in Rabies, 4th edition, pp. 433-445. Edited by F.-X. Meslin, M. Kaplan & H. Koprowski. Geneva: WHO.
27. Perrin, P., Thibodeau, L. & Sureau, P. (1985). Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre-and post-exposure protection studies. Vaccine 3, 325-332.
28. Perrin, P., Versmisse, P., Delagneau, J. F., Lucas, G., Rollin, P. E. & Sureau, P. (1986). The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus. Journal of Biological Standardization 14, 95-102.
29. Perrin, P., Joffret, M.-L., Leclerc, C., Oth, D., Sureau, P. & Thibodeau, L. (1988). Interleukin 2 increases protection against experimental rabies. Immunobiology 177, 199-209.
30. Perrin, P., De Franco, M., Jallet, C., Fouque, F., Morgeaux, S., Tordo, N. & Colle, J.-H. (1996). The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses. Research in Virology 147, 289-299.
31. Saron, M.-F., Fayolle, C., Sebo, P., Ladant, D., Ullmann, A. & Leclerc, C. (1997). Anti-viral protection conferred by recombinant adenylate cyclase toxins from Bordetella pertussis carrying a CDS+ T cell epitope from lymphocytic choriomeningitis virus. Proceedings of the National Academy of Sciences, USA 94, 3314-3319.
32. Smith, J., Yager, P. & Baer, G. (1996). A rapid fluorescent focus inhibition test (RFFIT) for determining virus-neutralizing antibody. In Laboratory Techniques in Rabies, 4th edition, pp. 181-189. Edited by F.-X. Meslin, M. Kaplan & H. Koprowski. Geneva : WHO.
33. Spier, R. E. (1997). Multivalent vaccines: prospects and challenges. Folia Microbiologica 42, 105-112.
34. Suhrbier, A. (1997). Multi-epitope DNA vaccines. Immunological Cell Biology 75, 402-408.
35. Thomson, S. A., Sherritt, M. A., Medveczky, J., Elliott, S. L., Moss, D. J., Fernando, G. J., Brown, L. E. & Suhrbier, A. (1998). Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. Journal of Immunology 160, 1717-1723.
36. Yokoyama, M., Zhang, J. & Whitton, J. L. (1995). DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. Journal of Virology 69, 2684-2688.